Business Wire

TX-MAVENIR

Share
CSPs Globally Adopting Mavenir’s Digital Enablement BSS Platform as they Transform for 5G Era

Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, today announced multiple Communications Service Providers (CSPs) are upgrading their Business Support System (BSS) with Mavenir’s Digital Enablement Platform (MDE) to offer new digital services that monetize 5G network investments.

MDE is a cloud-native, catalog-driven digital BSS that enables CSPs to easily create new 5G digital offerings or complete the 5G network transformation with charging and mediation functions and can also be used to design a digital marketplace experience, bundling cross-industry partner products and services into unified offerings. “With Mavenir’s MDE platform, CSPs can innovate fearlessly by rapidly introducing new services, and capture their customers’ interest, to become an integral part of their digital life,” said Sandeep Singh, GM Digital Enablement at Mavenir.

MDE can run as a comprehensive BSS or importantly, as a digital overlay with existing legacy BSS for minimal risk and disruption. BSS digital overlay systems can help CSPs to maximize returns in the 5G era. Analysys Mason forecasts, “The digital overlay approach can also reduce costs considerably, potentially saving CSPs up to 50% over 3-5 years when compared with traditional transformation approaches.1

Recent deployment examples of Mavenir’s MDE include:

- A leading CSP in Japan for business-to-business (B2B) mobility services

CSP successfully launched its Mobility Bundle Services targeted toward business customers. The typical service includes a bundle of SIM+Handsets purchased in bulk (10s-1000s). The BSS provided a first-of-its-kind agile, co-development, automated CI/CD enabling quarterly updates including modules like Product Catalog, CRM, CPQ, Order Management, Provisioning, Inventory tracking, Offline Rating & Charging, Billing, Invoicing, Payments and Collections.

Mavenir’s digital BSS, deployed as overlay BSS, is the primary for managing B2B customer account lifecycle and connects back to the existing consumer BSS, to leverage capabilities for Individual SIM activation, Number Portability workflow, Resource Inventory management and Network Mediation.

Deployment is on CSP's private cloud over the Kubernetes-based Containers-as-a-Service (CaaS) and Platform as a service (PaaS) layer.

- Large MVNO in Germany transitioning to MNO deploying MDE converged charging system (CCS) & Charging Gateway Function (CGF) for 4G+5G Converged Charging

Transitioning to becoming an MNO with owned RAN, Core, IT, BSS, and Charging system. The CCS includes the 4G OCS enabling Voice, SMS, Data service rating, and charging on real-time Diameter interfaces by integrating with the EPC and IMS network elements. The same core CCS engine also includes 5G CHF, integrated with Mavenir 5GC (5G Core) NFs. The Charging Gateway Function (CGF), also part of the CCS solution, provides for a modern microservice-based network and billing mediation functionality. While the first set of services, including 5G FWA is expected to go live in 2022, the solution is designed to deliver charging for Voice, Messaging, Data (4G+5G eMBB) and IoT in truly agile CI/CD based updates over the next two years. Deployment is on CSP's private cloud over the Kubernetes-based CaaS and PaaS layer.

- Greenfield CSP in Guyana selects MDE for E2E BSS and Charging

Deploying end-to-end BSS and Charging for their 4G+5G Mobile and Fixed Wireless service rollout. The first phase of this multi-phase enables the CSP to launch Prepaid LTE Voice, Data, and SMS services in 2022, leveraging a 4G OCS (Online Charging System) solution for prepaid voice, data, and messaging charging. The second phase will introduce Postpaid services built on top of the BSS. The final phase includes the launch of the 5G eMBB service that will be deployed using MDE 5G CCS integrated with the other vendor's 5GC.

Supporting material:
Mavenir Digital Enablement (MDE) Solution Brief
MDE Introduction Video
MDE Composable BSS Video
Mavenir’s Charging Gateway Function Solution Brief
Mavenir’s Converged Charging Solution Brief
Mavenir’s Converge Charging System Video

Other MDE resources –
MDE Digital Marketplace Whitepaper
MDE solution For MVNOs & Digital Brands
MDE IoT Business Management Solution Brief

About Mavenir:

Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industry's only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 250+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers. www.mavenir.com

1 Analysys Mason/Mavenir White Paper “BSS digital overlay systems can help CSPs to maximize returns in the 5G era ” – June 2022

Link:

ClickThru

Social Media:

https://www.facebook.com/Mavenir/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release

Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye